NCT04097366 Breast Screening - Risk Adaptive Imaging for Density Status ACTIVE_NOT_RECRUITING Phase NA
NCT04065269 ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03916510 Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1
NCT03908333 High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT03870152 Electrocautery Ablation for the Prevention of Lung Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT03797443 High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT03728881 Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial Status COMPLETED Phase PHASE3
NCT03720041 Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma Status UNKNOWN Phase PHASE3
NCT03705507 International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia Status TERMINATED Phase PHASE1/PHASE2
NCT03697239 High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT03562169 The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) Status RECRUITING Phase PHASE3
NCT03529669 Cytosponge™ for Post-Chemoradiation Surveillance of Oesophageal Cancer Status COMPLETED Phase NA